IL15 and cancer: Based on the previous results demonstrating that enhancing STAT activation with HODHBt increased the expression of several proteins involved in NK cell cytotoxicity, we were interested to test whether HODHBt also increased the ability of IL-15-activated NK cells to kill different cancer cell lines, including both hematologic and solid tumors, as well as HIV-infected cells.